The primary goal of this research study is to determine a safe dose for the drug oxaliplatin
when delivered by isolated hepatic perfusion. The second goal of this research study is to
determine if isolated hepatic perfusion with oxaliplatin can improve the efficacy of standard
hepatic arterial infusional (HAI) therapy with floxuridine (FUDR)/leucovorin.